✦ LIBER ✦

Prevend it (prevention of renal and vascular endstage disease intervention trial)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale, design, and baseline characte

✍ Gilles F.H. Diercks; Wilbert M.T. Janssen; Ad J. van Boven; Annette A.A. Bak; Pa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Sex differences in the association betwe

✍ Abbasi, A.; Corpeleijn, E.; Meijer, E.; Postmus, D.; Gansevoort, R. T.; Gans, R. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 169 KB

Long-term effects of fosinopril and prav

✍ Frank P. Brouwers; Folkert W. Asselbergs; Hans L. Hillege; Rudolf A. de Boer; Ro 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Secondary prevention with antioxidants o

✍ M Boaz; S Smetana; T Weinstein; Z Matas; U Gafter; A Iaina; A Knecht; Y Weissgar 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 96 KB

Increased risk of arterial thromboemboli

✍ Inge M. van Schouwenburg; Ron T. Gansevoort; Bakhtawar K. Mahmoodi; Margaretha M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Olmesartan Reducing Incidence of Endstag

✍ IMAI, Enyu; ITO, Sadayoshi; HANEDA, Masakazu; CHAN, Juliana C. N.; MAKINO, Hirof 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB